Health News Archive - May 19, 2011
SUNNYVALE, Calif., May 19, 2011 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that its president and chief executive officer, Euan S.
HAYWARD, Calif., May 19, 2011 /PRNewswire/ -- Metabolex, Inc., a biopharmaceutical company focused on the discovery and development of proprietary new medicines for the treatment of metabolic diseases, announced today that it has initiated a Phase 2 clinical trial of arhalofenate (MBX-102), its product candidate for the management of hyperuricemia in patients with gout. This randomized, double-blind, placebo-controlled study will evaluate the safety and urate-lowering activity of 400 and 600 mg of arhalofenate in 60 patients with hyperuricemia and a diagnosis of gout.
First ever clinical trial approved for SMA with a novel drug specifically designed to treat the disease CHICAGO, May 19, 2011 /PRNewswire-USNewswire/ -- Families of Spinal Muscular Atrophy announced today that Repligen Corporation has received approval from the U.S.
ATLANTA, May 19, 2011 /PRNewswire/ -- CardioMEMS, Inc., an Atlanta-based medical device company that has developed and is commercializing a proprietary wireless sensing and communication technology for the human body, announced today that its founder and CEO, Jay Yadav, M.D., is a finalist for the Ernst & Young Entrepreneur Of The YearÂ® award in the Alabama/Georgia/Tennessee region.
SANTA BARBARA, Calif., May 19, 2011 /PRNewswire/ -- If your doctor has the hasty reaction that a woman in her 30s is too young for hormonal imbalances, you may wind up being misdiagnosed as suffering from anything from stress to absolutely nothing -- the "it's all in your head" diagnosis.
SAN DIEGO, May 19, 2011 /PRNewswire/ -- Ardea Biosciences, Inc.
FLORHAM PARK, N.J., May 19, 2011 /PRNewswire/ -- PharmaDerm, a division of Nycomed US Inc., announced today that is has launched AK Connect, a patient resource program that contains information tailored to different types of patients about diagnosis, symptoms, treatment and support for actinic keratosis (AK).
SAN FRANCISCO, May 19, 2011 /PRNewswire/ -- Sutro Biopharma, a biopharmaceutical company developing novel and biosuperior protein therapeutics with improved pharmaceutical properties, today announced that a study published in the July issue of Biotechnology and Bioengineering demonstrates that the company's biochemical protein synthesis technology platform enables fast and high-yield protein synthesis and scale-up with straightforward downstream purification processes. In the study, the fully bioactive cytokine human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) was produced at linearly scalable levels from frozen extract of Sutro's E.coli-based open cell-free synthesis (OCFS) system.
To view the Social Media Release, click here: http://smr.newswire.ca/en/alberta-association-of-community-living/alberta-association-for-community-living CALGARY, May 19 /PRNewswire/ - The Alberta Association for Community Living (AACL) praised Mary Anne Jablonski, Minister of Seniors and Community Supports for accepting some key recommendations outlined in an administrative review to improve the Persons with Developmental Disabilities (PDD) program. However AACL notes that despite this progress many Albertans remain vulnerable. "While AACL applauds the minister's commitment to increasing support and flexibility for families with sons and daughters with developmental disabilities we remain deeply concerned about those individuals who require support but who don't qualify for the PDD program," said Barb MacIntyre, President of AACL and the mother of a son with developmental disabilities. AACL commends the ministry's commitment to achieving the best possible outcomes f
ENGLEWOOD, Colo., May 19, 2011 /PRNewswire/ -- In response to growing concerns about how to safely administer over-the-counter (OTC) liquid medications to children and the recent FDA Guidance for Industry on OTC delivery devices, Baxa Corporation, the leading provider of oral liquid drug delivery syringes, is available to discuss the following best practices for safe liquid medication administration at home and in hospitals: Can the Cup - Calling upon more than 35 years of work with leading pediatric care centers around the world and data from the ISMP (Institute for Safe Medication Practices), Baxa cautions against using dosing cups to administer liquid medication to infants and children.
- A bookseller; now, especially, a dealer in rare and curious books.